Provectus Biopharmaceuticals Inc (PVCT)

[Plegee]

PVCT's tweets this morning listed some superior PV-10 drug attributes, differentiating themselves from miRNA research and method of actions, that I would have thought would be more likely provided when in direct meetings with a bp to potentially secure their interest and financing.

By going public with it like we did, does that flag that no credible discussions are ongoing? It seems to me that one would not go public with that info unless they are purposely trying to mass market themselves to the bp community at large . . . . meaning promising discussions may not be currently underway with a specific bp. Do you have a read on the matter?? I'm probably getting to wrapped up over nothing, just do not want the momentum to stall. I'm hoping some clinical phase announcement is only a couple of quarters out at most.